>I have also been gathering evidence that blows apart the MSM narrative so if you're interested I'll do my best to post what I have in my research document.
Yes, please do!
I felt the same - it just did not make sense and there were some obvious lies upon which many decisions were predicated. I couldn't stand it anymore so just started grabbing whatever I saw on QR. Other anons are adding their findings, and we're grateful for all contributions.
Hydroxychloroquine Should Be Available Over the Counter
by John and Andy Schlafly
https://townhall.com/columnists/johnandandyschlafly/2020/07/15/hydroxychloroquine-should-be-available-over-the-counter-n2572496
It is time to take the bull by the horns to conquer the Wuhan virus. Drastic action is necessary, like on December 8, 1941 after Japan bombed Pearl Harbor.
President Trump should order immediate public access to hydroxychloroquine (HCQ) by making the medication available over-the-counter (OTC). Liberals have interfered with public access to this medication for COVID-19 through the old-fashioned route of requiring a prescription and then having a pharmacist fill or reject the prescription.
Millions of Americans do not visit physicians, and cannot obtain a prescription for HCQ if they did. Even if you have been exposed to COVID-19, you cannot obtain a prescription for HCQ in most states because regulators prohibit dispensing it without a positive test result, which typically cannot be obtained until late in the progression of the disease.
No one credibly doubts that HCQ is safe, and safer than many medications currently available OTC. No one credibly doubts the dozens of studies showing that early use of HCQ, pre-exposure and immediately after exposure to COVID, has helped many overcome this dreaded disease.
Americans do not need a prescription to obtain hundreds of medications which once required a prescription. Nexium, Prevacid, Prilosec, Claritin, Flonase, and Primatene Mist are medications that have been shifted from Rx to OTC in recent years, not because the medical establishment pushed for the change, but because of public demand for it.
No demand is higher at this time than for a medication which helps prevent against COVID. Yet Americans are not being allowed to access the medication which they want and need, and instead are being told by FDA and state officials that they cannot have it.
Last month the Oregon pharmacy board, for example, blocked HCQ access as follows: “Prescription orders for chloroquine or hydroxychloroquine for the prevention or treatment of COVID-19 infection may only be dispensed if written for a patient enrolled in a clinical trial by an authorized investigator.”
They based their ban on an improper statement issued by FDA, which is controlled by opponents of Trump’s reelection. Of course, many government officials in Oregon are against Trump, too.
Every state board of pharmacy or medicine is controlled by left-leaning government workers who, by and large, despise President Trump and hope he loses in November. They are accomplishing their dream by choking off public access to HCQ.
In other countries, such as Costa Rica and Honduras, HCQ is being given freely to the public to successfully defeat coronavirus there. In some countries officials are even going door-to-door distributing HCQ to build up protection against the virus, with great success.
The mortality rate from COVID-19 in the United States is far higher per case, and per million of residents, despite how we have the finest hospital system in the world. We don’t currently have public access to HCQ to protect against the disease, however, and that is what is needed at this time.
An executive order by President Trump, through use of his full emergency authority, could give Americans the same rights to HCQ for COVID which some of the poorest people in the world enjoy. Trump could even dispense HCQ at his rallies, which would both restore their massive numbers and help safeguard against spread of the virus.
But the medical establishment, such as Dr. John Fleming who is advising Trump’s Chief of Staff Mark Meadows, is impeding this solution to the crisis. As a physician, Dr. Fleming is instinctively trained to oppose OTC status for most medications, and he is beholden to the mindset of requiring people to see physicians first.
Americans are accustomed to being advised to consult a physician before starting a weight-loss plan, an attorney before writing a will, and an accountant before filing a tax return. In ideal situations, recommending use of a professional is non-controversial.
When there is a crisis, however, the dynamic is different. When thousands are dying unnecessarily, and millions are paralyzed by fear, directly alleviating that mortality and fear becomes paramount.
There is no valid reason to deny public access to low-dose HCQ, which studies show can protect against COVID, just as there is no legitimate reason to require a prescription for low-dose steroid cream (Cortisone) and many other over-the-counter medications. The political motivation to block access to HCQ justifies making it publicly available.
This is not a decision for Anthony Fauci or the medical establishment or FDA to make during a national crisis. This is for President Trump to decide, and make HCQ available quickly to the public.
If an intruder is discovered in one’s home in the middle of the night, no responsible father tries first to call an expert to get an opinion about what to do. Instead, quick and decisive action is taken, and that means OTC status for HCQ to conquer COVID.
John and Andy Schlafly are sons of Phyllis Schlafly (1924-2016) and lead the continuing Phyllis Schlafly Eagles organizations with writing and policy work.
>>>/qresearch/9974504
Cloth masks: Dangerous to your health?
Date: April 22, 2015
https://www.sciencedaily.com/releases/2015/04/150422121724.htm
Summary:
Respiratory infection is much higher among healthcare workers wearing cloth masks compared to medical masks, research shows. Cloth masks should not be used by workers in any healthcare setting, authors of the new study say.
The widespread use of cloth masks by healthcare workers may actually put them at increased risk of respiratory illness and viral infections and their global use should be discouraged, according to a UNSW study.
The results of the first randomized clinical trial (RCT) to study the efficacy of cloth masks were published in the journal BMJ Open.
The trial saw 1607 hospital healthcare workers across 14 hospitals in the Vietnamese capital, Hanoi, split into three groups: those wearing medical masks, those wearing cloth masks and a control group based on usual practice, which included mask wearing.
Workers used the mask on every shift for four consecutive weeks.
The study found respiratory infection was much higher among healthcare workers wearing cloth masks.
The penetration of cloth masks by particles was almost 97% compared to medical masks with 44%.
Professor Raina MacIntyre, lead study author and head of UNSW's School of Public Health and Community Medicine, said the results of the study caution against the use of cloth masks.
"Masks are worn to protect from infection during pandemics and outbreaks, especially when there are no drugs or vaccines available for protection," Professor MacIntyre said.
"Masks are especially important for frontline doctors and nurses, as their protection from infection is key to maintaining the ability to tackle a pandemic effectively.
"We should be cautious about cloth mask use in healthcare settings, particularly high-risk situations such as emergency departments, intensive care, paediatric or respiratory wards."
Cloth masks remain widely used globally because they are a cheaper option especially in areas where there are shortages of protective equipment, including in Asian countries, which have historically been affected by emerging infectious diseases, as well as in West Africa, which was the epicentre of the recent Ebola epidemic.
The authors speculate that the cloth masks' moisture retention, their reuse and poor filtration may explain the increased risk of infection.
Professor MacIntyre, who has completed the largest body of clincial trial research on respiratory protection in health workers internationally, said emerging infectious diseases are not constrained within geographical borders.
"Effective controls of outbreaks and pandemics at the origin impacts us directly, so it is important for global disease control that the use of cloth masks be discouraged in high-risk situations," she said.
"Despite more than half the world using cloth masks, global disease control guidelines, including those from the World Health Organisation, fail to clearly specify conditions of their use.
"These guidelines need to be updated to reflect the higher infection risk posed by cloth masks, as found in our study."
Professor MacIntyre said the study's results pointed to the effectiveness of medical masks, in addition to the harm caused by cloth masks.
"Additional research is urgently needed to build on our study's findings."
The trial was a collaboration between researchers in Australia and the National Institute for Hygiene and Epidemiology in Vietnam and was funded by an Australian Research Council Linkage Grant.
A separate expert review by Professor MacIntyre published in the British Medical Journal earlier this month found that the lack of research on facemasks and respirators is reflected in varied and sometimes conflicting global policies and guidelines.